CONTEXT: It’s awards season and as we wait to see who will be glammed up from the waist up at the Oscars, another RWE report is issued with even bigger numbers being touted for RWE growth across the industry. Where do they get these numbers from and will anyone beat Nomadland?
IMPACT: Low
READ TIME: 2 mins
Quality Level Mean [1 – 10]: 3
1. “Global Size, By Application Type (Remote Medicine Management, Electronic Health Record & Clinical Workflow, Outpatient Vigilance, Medical Connected Imaging, Medical Assistance), By Connectivity (Wired and Wireless), By Component (Hardware and Software & Services), By Region (North America, Europe, Asia Pacific, South America, and the Middle East & Africa), Trend Analysis, Market Competition Scenario & Outlook, 2016-2026. Global Market Size by Products & Services (Hematology Analyzers (5 Parts, 6 Parts, 3 Part, PoC, Semi-Automated), Hemostasis, Immunohematology), by Price Range (High, Medium and Low), By Application (Anemia, Blood Cancer, Hemorrhagic Conditions, Infection-Related Conditions, Immune System Related Conditions, and Others), By End-User (Hospital Laboratories, Blood Banks, Commercial Service Providers, Government Reference Laboratories, Research & Academic Institute, and Others), By Region (North America, Europe, the Asia-Pacific, South America, and the Middle-East & Africa)Trend Analysis, Competitive Market Share & Forecast, 2021-2027.”
2. “The presence of a favorable regulatory environment, a high number of RWE service providers, the presence of a well-established pharmaceutical industry in the region, coupled with the high R&D expenditure, are the major factors responsible for the large share of North America in the global real-world evidence market.”
3. “The U.S. is expected to dominate the North American market, owing to a high demand in clinical research activities, which is one of the important factors augmenting the demand for real-world evidence solutions market in the North America region.”
4. “Global , By Application (Electronic Health Record, Computerized Provider Order Entry Systems, Electronic Prescribing Systems, PACS, Laboratory Information Systems, Clinical Information Systems, Tele-Healthcare, Others), By (North America, Europe, Asia Pacific, and Rest of the World); Trend Analysis, Competitive Market Share & Forecast, 2020-2026.”
5. “Global , By Test Type (Cell-Based Assays, Virology Testing, Species-Specific Viral PCR Assays, Serology, Immunogenicity & Neutralizing Antibodies, Biomarker Testing, Pharmacokinetic Testing, Other Services); By Molecule Size (Smaller Molecule and Larger Molecule); By Application, Oncology, Neurology, Infectious Diseases, Gastroenterology, Cardiology, Other Applications);By End-Users (Pharmaceutical and Biopharmaceutical Companies Therapeutic, Contract Development and Manufacturing Organizations, Contract Research Organizations); By Region (North America, Europe, the Asia-Pacific, the Middle East & Africa, and Latin America) Trend Analysis, Competitive Market Share & Forecast, 2017-2027. Global , By Type (Private Blockchain and Public Blockchain); By Application (Clinical Data Exchange & Interoperability, Claims Adjudication & Billing, Supply Chain Management, Clinical Trials & e-Consenting, & Others); By End-Use (Pharmaceutical Company, Healthcare Providers, Healthcare Payers, & Others); By Region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa); Trend Analysis, Competitive Market Share & Forecast, 2017-2027. Global , By Type (Tele-Hospital and Tele-Home), By Application (Teleradiology, Tele-ICU, Telestroke, Tele-pathology, Tele-dermatology, Tele-psychiatry, and others);By Mode of Delivery: Web/Mobile-based, Telephonic, Visualized Access to Healthcare; By End-Use (Healthcare Prov”